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A rare desmoid tumor of the shoulder – excision,
implantation of brachytherapy applicators and wound
closure by pedicle musculus latissimus dorsi flap
Ein seltener Desmoidtumor der Schulter – Exzision, Implantation von
Brachytherapie-ApplikatorenundDefektdeckungmitgestielterMuskulus
Latissimus Dorsi Lappenplastik
Abstract
Desmoid tumors are non-metastatic mesenchymal tumors with an ag-
gressive local growth. Depending on the anatomic location, morbidity
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Zusammenfassung
Desmoidtumoren sind seltene, nicht-metastasierende mesenchymale
Tumore mit einem lokal agressiv-infiltrativen Wachstum. Wir berichten
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über einen Patienten, der aufgrund eines Desmoidtumors in unserer
Abteilung durch Exzision, plastisch-chirurgische Defektdeckung und
einer adjuvanten Bestrahlung behandelt wurde.
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Introduction
Desmoidtumorsarerareentitiesandbelongtothegroup
of fibromatoses, which arise from the connective tissue,
fascia or aponeurosis of a muscle [1].
Even though desmoid tumors are benign lesions per
definition,theyshowaninfiltrativegrowthwithdestruction
of surrounding structures and neighbouring organs, re-
sultinginextensivemorbidity[2].Theincidenceisreport-
ed to be 2.4 bis 4.3 cases/1 million/year.
In the majority desmoid tumors are found intraabdomin-
ally and only a small amount of 7–15% are found in the
head and neck area. As this tumor entity is rare, data
giving evidence based recommendations for the optimal
treatment algorithm for this disease is lacking [3].
We report the case of a patient with a desmoid tumor of
therightshoulderregionthatwasdiagnosedandtreated
interdisciplinary in the general surgery department for
tumor resection, in our department for plastic surgical
woundclosureandinradio-oncologyforadjuvantbrachy-
therapy.
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Case Report OPEN ACCESSFigure1:PreoperativeMRIoftherightshouldershowingthetumora)intransversecross-sectionwithTumor(Tu/arrow)8x6x3.5
cm, Clavicle (Cla) and b) in relation to neighboring structures such as Humerus (Hu), Processus coracoideus (Prc).
Figure 2: a) Excision of the tumor and parts of deltoid muscle, b) separation from humerus (Hu) and processus coracoideus
(Prc) and M. biceps brachii caput longum, c) resulting wound cavity with exposed humerus and clavicle (Cla) d) tumor mass
with overlying skin spindle after resection.
Case description
A 52-year old Caucasian German male with no past
medical history had observed a rapidly growing tumor of
his right shoulder and slight soreness during a period of
four weeks after having performed physical exercise for
several weeks in a fitness studio. He reported an allergy
against contrast medium. The tumor was palpable as a
firm lump of the ventral shoulder. An external magnet
resonance imaging (MRI) showed an 8x4x5.3 cm soft
tissue tumor of the ventral shoulder below the deltoid
muscle overlying the humerus head. Furthermore, the
tumor had contact to the biceps muscle and the axillary
perivascular sheath (Figure 1).
After completion of preoperative staging, the tumor was
excisedintotobythegeneralsurgerydepartment.Resec-
tion was achieved without harming neuro-vascular
structures but part of the deltoid muscle had to be ex-
cised. After resection, the resulting wound cavity was too
large to be closed by plain skin suture (Figure 2 a–c).
Thefinalhistologyrevealedan8cmmeandiametercrude
mass with elongated spindle-shaped cells, intertwined
byalargeamountofcollagen-fibres.Thetumorexpressed
vimentin and actin but immuno-staining did not show
pancytokeratin expression. The S100 antigen, desmin
and CD117 (C-kit) were negatively tested. All resection
lines were free of tumor.
Intheplasticsurgerydepartment,thepatientunderwent
surgeryforwoundclosurebyapediclemusculuslatisimus
dorsi flap from his right back and a sheet skin graft from
his left thigh. Intraoperatively, region of radiation target
area was marked by placing several metal surgical clips,
as well as eight brachytherapy applicators (plastic tubes)
whichwereimplantedparallelusingonecminterspacing
between each tube (Figure 3). The applicators were fixed
to the tumor bed with single sutures so that latero-lateral
movement was blocked but longitudinal movement was
kept free. After inserting the tubes through the skin they
were fixed by special buttons, which were sutured to the
skin to avoid longitudinal movements. Postoperatively, a
multislice CT (1 mm slice thickness) was performed in
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Stollwerck et al.: A rare desmoid tumor of the shoulder – excision, implantation ...Figure 3: a+b) Wound closure achieved by pedicle musculus latissimus dorsi flap and split skin graft and implantation of 8
afterloading applicators. (Day 1 after operation)
Figure 4: a–e) Brachytherapy dose distribution on the 2D and 3D level.
Figure5: a–c)6 Weeksafterremoval of afterloadingtubes(Brachtherapy) stable muscle flapand skin graftas wellas maturing
scar of the right flank after harvest of M. latissimus dorsi. Good arm mobility with 90° shoulder abduction. d+e) stable skin
graft and muscle flap at follow-up 1 year after treatment.
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tors.Basedonthismodel,anindividualvolumeoptimized
dosedistributionwascalculatedbyusingtheBrachyvision
software package (Varian, USA). After completing the
fractionated image adapted brachytherapy treatment
(IABT)thefixingbuttonswereremovedandtheapplicators
could be extracted without any anaesthesia. During the
postoperative course, no adverse events were recorded.
Because of the high risk of local recurrences in solitary
surgery and the current tumor size of eight cm, radiation
therapy (RT) was recommended in the interdisciplinary
tumor board and brachytherapy was initiated with a total
of 30 Gy (2x2.5 Gy in 8 days, no radiation on Saturday
and Sunday) two weeks after achievement of wound
closure. Representative images of dose distribu-
tion(Figure4)showtheoptimalradiationcoverageofthe
target area.
After completion of radiation, patient was treated by a
physysiotherapist for the mobilization of the shoulder.
After6monthsacontrolMRIwasperformedwithnosigns
of a recurrent tumor. The patient was very satisfied with
the result of the muscle flap (Figure 5).
Discussion
Desmoid tumors originate from muscular connective tis-
sue,fasciaeandaponeurosis.Theirgrowthtypicallyshows
to be locally invasive, yet without a metastatic tendency.
Theunderlyingcelldifferentiationcontainsspindleshaped
cells, which are intertwined by collagen fibres. The inci-
dence is reported to be 2.4 bis 4.3 cases/1 million/year,
whilst the majority of desmoid tumors are found intraab-
dominally and only 7–15% are found in the head and
neck area. When a surgeon is challenged by needing to
treattherareentityofadesmoidtumor,heneedstotake
the high risk of recurrence (25–65%) [4] after surgery
into account.
The etiology of aggressive fibromatosis has not been
sufficientlyexplained,buttrauma,endocrineandgenetic
factors have been suggested to be causative [4].
Inthepresentedcasethepatientreportedtohaveunder-
goneextensivemuscletrainingbeforethetumoroccurred.
Thisleadstotheassumption,thatthegrowthofthetumor
could have been induced by this trauma to the muscle
and its tendons.
Diagnostics should be performed by ultrasound, MRI or
CT-scans. Before any type of surgery is performed, the
expansion of the tumor and its relation to functional
structures and the neuro-vascular system need to be
identified.
Successful treatment of aggressive fibromatosis can be
achievedbysurgicalexcision,radiationandwithpharma-
cological agents.
In the current literature, radical surgical excision with tu-
mor-free margins up to 3 cm is widely accepted and re-
commended [5], [6]. However, this often confronts the
surgeonwiththedifficultyofhavingtosacrificestructures
of functional or even vital importance. If a complete re-
section cannot be achieved because vital structures i.e.
large blood vessels and vital organs are in danger, this
fact consequently leads to local recurrence with a poor
outcome. Further problems arise if a large wound cavity
results, which cannot be closed by direct skin suture.
Nonetheless, radical excision should not be avoided, as
sufficient wound closure can be provided by plastic sur-
gery as shown in the present case.
In cases of incomplete resection, the role of adjuvant ra-
diationorpharmacologicaltreatmentbecomesevenmore
important to limit the rate of recurrence and need to be
discussed rationally in an interdisciplinary tumor board.
There are studies, which emphasize the effectiveness of
adjuvant radiation [7], [8], [9], [10], [11]. However, a re-
cent 24-year retrospective study demonstrated 3-year
local control rates without significant differences after
surgery, radiotherapy or a combination of both. Patients
were selected for treatment branches according to the
size of the tumor, the expansion of the tumor and the
possibilityofachievingmarginfreeresection.Theactuar-
ial3-yearlocalcontrolratesrangedfrom69.0%to92.3%
[12].
In a further retrospective study of 115 patients with
desmoid tumors Guadagnolo et al. described that the
recurrencewithRTalonecanamountupto32%incases
where surgery is not feasible due to gross disease. Pa-
tients treated with both surgery and RT showed a lower
localrecurrenceoftheirtumorof20%.Yetincomparison
the combination of surgery and RT did not prove to show
different local control rates than in solitary RT. Addition-
ally, in the case of positive resection margins, the combi-
nation of RT and surgery, did not show to be significantly
associated with a lower rate of local control [5].
Nuyttens et al. demonstrated in a literature review that
RT alone or surgery in combination with RT results in
significantly better local control than just with solitary
surgery. Subdividing the groups into cases with free and
positive margins and cases with primary and recurrent
tumors showed that the best local control is achieved
with RT or surgery with RT [10].
Intraoperativeradiotherapywasproventobeaneffective
treatment with low toxicity [6] and a total dose below
56 Gy was recommended [5].
Interstitial brachytherapy offers minimal normal tissue
toxicity due to the steep dose fall-off of the sources and
duetotheintraoperativeapplicatorplacementthetarget
tissue for postoperative radiotherapy can be defined op-
timally. Regarding total dose values, a National Patterns
of Care Study on radiotherapy of desmoid tumors [11]
showedanover80%curerateintheadjuvantdoserange
of 36–65 Gy. Radiobiological modelling by the use of the
linear-quadratic (LQ) model allows the calculation of the
biologicalequivalentdose(BED)oftheusedfractionation
schedule [13] and results in a total BED of 46.5 Gy on
the reference isodose. However, tissue volumes near to
the applicators will be irradiated with higher dose (for
example the volume covered by the 200% isodose line
with BED 93.0 Gy). The quality of the implant can be de-
scribed by the dose non-homogeneity ratio (DNR), which
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covered volume of the 100% isodose line. In this case it
was0.39–indicatingahomogenousbrachytherapydose
distribution.
Pharmacological treatment of desmoids tumors offers
further effective possibilities, if the biological properties
andthepatient'scharacteristicsaresuitable.Optionsare
cytostatic chemotherapy, and non-cytotoxic agents such
as hormonal, anti-inflammatory and biological agents
[14]. Unfortunately, also in the field of pharmacological
treatmentthereisalackofevidenceduetonon-sufficient
patient numbers and missing prospective randomized
studies.
Thisshowsthatitismorethanevernecessarytoestablish
treatmentalgorithmsbyinducingprospectivemulticenter
studies – also in this rare entity.
Conclusion
Thesuccessfultreatmentofdesmoidtumorsrequiresan
interdisciplinary approach. In cases of large tumors in
need of wide excision, a plastic surgeon needs to be
consultedtoensureradicalexcisionandsufficientwound
closure.Woundclosurewithviabletissueallowseffective
adjuvant radiation therapy. Normal tissue sparing and
effective adjuvant therapy strategies are the implemen-
tation of perioperative image adapted brachytherapy
techniques,aswellpharmacologicalagentssuchasanti-
estrogens (i.e. Tamoxifen) and non-steroidal anti-inflam-
matory drugs (NSAID). There is a need for prospective
randomized studies with larger numbers of patients to
allow the development of standardized and evidence-
based treatment algorithms.
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